Washington Gastroenterology, Tacoma

Tacoma, Washington 98405

4 studies enrolling now · 8 studies all time

What they study most

Cirrhosis, Crohn's Disease, Hepatitis B, Hepatocellular Cancer, Hepatocellular Carcinoma, Liver Cancer, Metabolic Dysfunction-Associated Steatotic Liver Disease, Obesity or Overweight, Pouchitis, Ulcerative Colitis, Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate

Studies at this site

• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study — Recruiting now
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk — Running, not enrolling
• Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis — Completed